TerrAscend (TSNDF) Cost of Revenue (2021 - 2026)
TerrAscend (TSNDF) reported Cost of Revenue of $30.9 million for Q1 2026, up 4.44% year-over-year from $29.6 million in Q1 2025, and down 2.3% quarter-over-quarter from $31.7 million in Q4 2025.
TerrAscend (TSNDF) Cost of Revenue (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Cost of Revenue data on file, last reported at $30.9 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $30.9 million, up 4.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.6 million (down 0.93% YoY), and the FY2025 annual result was $124.2 million, down 6.03% from the prior year.
- Cost of Revenue fell to $30.9 million in Q1 2026 per TSNDF's latest filing, from $31.7 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $41.9 million in Q1 2024 and troughed at -$339000.0 in Q4 2023.
- A 5-year average of $32.5 million and a median of $33.0 million in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2023 and 2024: Cost of Revenue plunged 100.89% in 2023, then jumped 9338.64% in 2024.
- A 5-year view of Cost of Revenue shows it stood at $38.2 million in 2022, then sank by 100.89% to -$339000.0 in 2023, then jumped by 9338.64% to $31.3 million in 2024, then climbed by 1.11% to $31.7 million in 2025, then declined by 2.3% to $30.9 million in 2026.
- Business Quant data shows TSNDF's Cost of Revenue at $30.9 million in Q1 2026, $31.7 million in Q4 2025, and $31.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 30.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.94 Mn |
| Mar 31, 2026 | 30.94 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Sep 30, 2025 | 31.18 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Jun 30, 2025 | 31.77 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Mar 31, 2025 | 29.62 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Dec 31, 2024 | 31.32 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Sep 30, 2024 | 31.95 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 33.84 Mn |
| Mar 31, 2024 | 41.90 Mn |
| Mar 31, 2024 | 41.90 Mn |
| Dec 31, 2023 | -339,000.00 |
| Dec 31, 2023 | -339,000.00 |